EOG Resources vs Occidental Petroleum
EOG and OXY side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EOG and OXY compare
EOG Resources is the larger company, worth 1.4 times as much as Occidental Petroleum ($80.7B against $57.2B).
On earnings, Occidental Petroleum is cheaper: it trades at 7.7× trailing earnings, against 9.9× for EOG Resources.
Occidental Petroleum grew revenue faster over the last twelve months (34.7% versus 31.7% for EOG Resources).
Both pay dividends: EOG Resources yields 2.7% and Occidental Petroleum 1.8%.
EOG Resources scores higher on the StockData Score (17 against 11 for Occidental Petroleum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EOG | OXY |
|---|---|---|
| Size and price | ||
| Market cap | $80.7B | $57.2B |
| Share price | $153.77 | $57.24 |
| Change, 1 year | 44.3% | 36.9% |
| Change, 5 years | 79.5% | 96.6% |
| Beta (5Y) | 0.55 | 0.42 |
| Employees | 3,400 | 6,793 |
| StockData Score | ||
| Total score | 17 (better) | 11 |
| Valuation score | 4 | 5 (better) |
| Growth score | 1 | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 6 (better) | 4 |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/E | 9.9× | 7.7× (better) |
| P/S | 2.7× | 2.3× (better) |
| P/B | 2.4× | 1.3× (better) |
| EV/EBITDA | 5.3× | 4.5× (better) |
| P/FCF | – | 9.8× |
| FCF yield | – | 10.3% |
| Fair value | $181.07 | $78.43 |
| Margin of safety | 15.1% | 27.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 31.7% | 34.7% (better) |
| Revenue growth, 5Y average | 15.5% (better) | 3.9% |
| Net income growth (TTM) | 48.0% | – |
| EPS growth (TTM) | 53.9% | 438% (better) |
| Profitability | ||
| Operating margin | 35.8% | – |
| Net margin | 27.5% | – |
| FCF margin | – | 23.5% |
| Return on equity | 25.8% | – |
| Return on invested capital | 23.8% | – |
| Financial health | ||
| Debt / equity | 0.24 (better) | 0.27 |
| Net debt / EBITDA | 0.14 (better) | 0.55 |
| Interest coverage | 40.1× | – |
| Current ratio | 1.90 (better) | 1.38 |
| Altman Z-score | 4.22 (better) | 1.82 |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | 2.7% (better) | 1.8% |
| Years of dividend growth | 1 | 4 (better) |
| Dividend growth, 5Y average | 21.6% (better) | 3.2% |
| Buyback yield | 4.3% (better) | −0.25% |
| Shareholder yield | 6.9% (better) | 1.6% |
| Ownership | ||
| Held by institutions | 96.5% | 83.6% |
| Held by insiders | 0.23% | 0.39% |
| Insider net buying, 12 months | −$10.8M | $445K (better) |
| Superinvestors holding | 2 | 2 |
| Short interest, % of float | 3.2% | 2.7% |
Go deeper
- EOG stock overview
- EOG income statement
- EOG valuation and score
- OXY stock overview
- OXY income statement
- OXY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.